Key facts
- Notable investors include LLR Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for TruTechnologies
- ·The full record, as it builds
Funding rounds
No funding rounds for TruTechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TruTechnologies
Developer of a real-time clinical trial oversight platform intended for constant remote accessioning of samples. The company's platform leverages blockchain to ensure biological sample tracking and clinical site monitoring to accelerate patient screening and enrollment, drive protocol adherence, and correct deviations, enabling biotechs and pharma to get timely, quality data and mitigate risks in drug development.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2018
- Employees
- 72
- Website
- trutechnologies.io/
- Ownership
- Privately Held (backing)
TruTechnologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TruTechnologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TruTechnologies in its N-PORT filings yet. We sweep new filings monthly.